D2Sbiosolutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-06-2024
- Paid Up Capital ₹ 10.00 K
as on 30-06-2024
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About D2Sbiosolutions
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Dileep Nair, Satish Gopalakrishnan, and Sunil Gopinath serve as directors at the Company.
- CIN/LLPIN
U73100KL2022PTC076877
- Company No.
076877
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2022
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at D2Sbiosolutions?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Gopinath  | Managing Director | 19-Jul-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dileep Nair | Director | 19-Jul-2022 | Current |
| Satish Gopalakrishnan | Director | 19-Jul-2022 | Current |
Financial Performance and Corporate Structure Insights of D2Sbiosolutions.
Enhance accessibility to D2Sbiosolutions's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of D2Sbiosolutions?
Unlock access to D2Sbiosolutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vektor Innovations Private LimitedActive 11 years 7 monthsSatish Gopalakrishnan and Sunil Gopinath are mutual person
- Breathelife Biosciences Private LimitedInactive For E-Filing 6 months 11 days
Dileep Nair is a mutual person
- Vektron India Private LimitedActive 3 years 9 months
Satish Gopalakrishnan and Sunil Gopinath are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at D2Sbiosolutions?
D2Sbiosolutions has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D2Sbiosolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D2Sbiosolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
